Technische Daten
Reaktivität AK: | Human, others not tested. | Format AK: | Ready-to-use | Klon: | Polyclonal | Spezies: | Rabbit | Ig Unterklasse: | IgG | Immunogen: | Synthetic peptide of human Caveolin-1 | Anwendung AK: | IHC(p),IHC(f) | Fixierung: | 1) NOTOXhisto 2) Formalin | Zelluläre Lokalisation: | Membranous, cytoplasmic | Kontrolle: | Placenta, mesothelioma | Lagerung AK: | Store at 2 - 8 °C. Do not use after expiration date indicated on the vial. | Synonyme: | opamine D3 receptor, Caveolin1, Caveolin 1, 3 dopamine receptor, D, Dopamine receptor D3, DRD, ETM1, FET1, Cav-1, ETM1, CAV 1, CAV1, CAV1_HUMAN. | Verfügbar in folgenden Ländern: | world wide (except US) | Status: | IVD |
Beschreibung
Caveolins are a family of integral membrane proteins that are the principal components of caveolae membranes and involved in receptor-independent endocytosis. Three members of this family exist. The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. Caveolin 1 is most prominently expressed in endothelial, fibrous, and adipose tissue. Caveolins have been implicated in both tumor suppression and oncogenesis. High expression of caveolins leads to inhibition of cancer-related pathways, such as growth factor signaling pathways. However, certain cancer cells that express caveolins have been shown to be more aggressive and metastatic.
Literatur
[1] Amatya VJ, Takeshima Y, Kohno H et al. (2009):
Caveolin-1 is a novel immunohistochemical marker to
differentiate epithelioid mesothelioma from lung
adenocarcinoma. Histopathology. 55(1):10-9.
[2] Hehlgans S, Cordes N (2011): Caveolin-1: an
essential modulator of cancer cell radio-and
chemoresistance. Am J Cancer Res. 1(4):521-30.
[3] Quann K, Gonzales DM, Mercier I et al. (2013):
Caveolin-1 is a negative regulator of tumor growth in
glioblastoma and modulates chemosensitivity to
temozolomide. Cell Cycle. 12(10):1510-20.
[4] Sloan EK, Ciocca DR, Pouliot N et al. (2009): Stromal
cell expression of caveolin-1 predicts outcome in breast
cancer. Am J Pathol. 174(6):2035-43.
[5] Glenney JR Jr (1992): The sequence of human
caveolin reveals identity with VIP21, a component of
transport vesicles. FEBS Lett. 314(1):45-8.
|